prophets, on Dec 16 2009, 06:14 PM, said:
Quote
==================
Saturated | 9.5 g
Monounsaturated | 39.5 g
Polyunsaturated | 20.9 g
Omega-3 | 7.6 g 190%
Omega-6 | 13.2 g
Trans-Fats | 0.0 g
Cholesterol | 30.8 mg 10%
Phytosterol | 136.2 mg
It's also worth noting that the CVD benefits of omega-3 of any form are actually (and very surprisingly) somewhat in doubt (3).
VespeneGas, on Dec 16 2009, 07:05 PM, said:
FunkOdyssey, on Dec 30 2009, 01:56 PM, said:
maxwatt, on Dec 28 2009, 11:13 AM, said:
kismet, on Dec 24 2009, 09:45 PM, said:
maxwatt, on Dec 28 2009, 11:13 AM, said:
Statins cause myalgia in perhaps 1-5% of patients, and analyses of large patient databases from FDA (4) and large HMOs (5) found a rate of actual rhabdomyolysis from monotherapy in currently-approved statins to be ≤ 1.18 per 100,000 prescriptions -- though muscle damage visible on electron microscopy and other analyses persists in patients who discontinue following myalgia symptoms alone (6) To take a more extreme example, < 1 in 10 long-term smokers develop lung cancer, and it takes decades to show up. There is a reason why, even accounting for Big Tobacco malfeasance, the association was not well-established until well into the late 20th century.
-Michael
1. Therapeutics initiative for evidence-based drug therapy. COX-2 inhibitors update: Do journal publications tell the full story? Ther Letter 2001–2002; 43(Nov-Dec/Jan):1-2.
2. Wooltorton E. What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex). CMAJ. 2002 Jun 25;166(13):1692-3.
PubMed PMID: 12126328; PubMed Central PMCID: PMC116160.
3. León H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008 Dec
23;337:a2931. doi: 10.1136/bmj.a2931. Review. PubMed PMID: 19106137
4. Chang JT, Staffa JA, Parks M, Green L. Rhabdomyolysis with HMG-CoA reductase
inhibitors and gemfibrozil combination therapy. Pharmacoepidemiol Drug Saf. 2004
Jul;13(7):417-26. PubMed PMID: 15269925.
5. Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz
JH, Chan KA, Goodman MJ, Platt R. Incidence of hospitalized rhabdomyolysis in
patients treated with lipid-lowering drugs. JAMA. 2004 Dec 1;292(21):2585-90.
Epub 2004 Nov 22. PubMed PMID: 15572716.
6. Mohaupt MG, Karas RH, Babiychuk EB, Sanchez-Freire V, Monastyrskaya K, Iyer L,
Hoppeler H, Breil F, Draeger A. Association between statin-associated myopathy and skeletal muscle damage. CMAJ. 2009 Jul 7;181(1-2):E11-8. PubMed PMID:
19581603; PubMed Central PMCID: PMC2704421.
Edited by Michael, 31 December 2009 - 10:47 PM.
Adding statin example





















